ArticleOncotarget2021

Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine.

Balraj Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.